Description
What is it?
Ursactive Capsule is a medication that contains Ursodeoxycholic Acid as its active ingredient. This acid is naturally produced in the body and helps regulate the amount of cholesterol in the bile. When the levels of cholesterol are too high, it can lead to the formation of gallstones.
Usage
Ursactive Capsule is primarily used for the treatment of primary biliary cirrhosis (PBC) and for preventing gallstones. It works by dissolving the cholesterol that makes gallstones and inhibiting the production of cholesterol in the liver and absorption in the intestines. This decreases the formation of gallstones and reduces the amount of other bile acids that can be harmful to liver cells when levels are elevated.
Dosage
The recommended adult dosage for Ursactive Capsule in the treatment of PBC is 13-15 mg/kg/day administered in two to four divided doses with food. The dosing regimen should be adjusted according to each patient’s needs at the discretion of the physician.
Side Effects
Common side effects of Ursactive Capsule may include diarrhea and sticky stool. In rare cases, it may cause calcification of gallstones and urticaria. Other side effects that have been reported include nausea, vomiting, and itching.
Precautions
It’s important to note that Ursactive Capsule can increase the absorption of ciclosporin from the intestine. If you’re receiving ciclosporin treatment, your blood concentrations of this substance should be checked by a physician, and the ciclosporin dose should be adjusted if necessary. In isolated cases, Ursactive Capsule can reduce the absorption of ciprofloxacin.
Conclusion
Ursactive Capsule is a natural solution for those suffering from gallstones or primary biliary cirrhosis. Its active ingredient, Ursodeoxycholic Acid, works by dissolving cholesterol and reducing the formation of gallstones. As with any medication, it’s important to follow the recommended dosage and consult with a physician if you have any concerns or experience any side effects.
Reviews
There are no reviews yet.